{
  "id": "a9f53b6671940ff4",
  "title": "A common constipation drug shows a surprising ability to protect kidneys",
  "description": "A surprising link between constipation and kidney decline led researchers to test lubiprostone, revealing that it can protect kidney function. The results point toward gut-based, mitochondria-boosting therapies as a promising new avenue for CKD care.",
  "content": "A surprising link between constipation and kidney decline led researchers to test lubiprostone, revealing that it can protect kidney function. The results point toward gut-based, mitochondria-boosting therapies as a promising new avenue for CKD care.",
  "source": "Health & Medicine News -- ScienceDaily",
  "source_url": "https://www.sciencedaily.com/releases/2025/12/251203004731.htm",
  "published_at": "2025-12-03T13:47:23+00:00",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "A common constipation drug shows a surprising ability to protect kidneys",
    "description": "A surprising link between constipation and kidney decline led researchers to test lubiprostone, revealing that it can protect kidney function. The results point toward gut-based, mitochondria-boosting therapies as a promising new avenue for CKD care.",
    "url": "https://www.sciencedaily.com/releases/2025/12/251203004731.htm",
    "published": "2025-12-03T13:47:23+00:00",
    "source": "Health & Medicine News -- ScienceDaily"
  }
}